Guang Ji

10.6k total citations · 3 hit papers
280 papers, 7.4k citations indexed

About

Guang Ji is a scholar working on Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Guang Ji has authored 280 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Epidemiology, 123 papers in Molecular Biology and 38 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Guang Ji's work include Liver Disease Diagnosis and Treatment (110 papers), Lipid metabolism and disorders (30 papers) and Diet, Metabolism, and Disease (29 papers). Guang Ji is often cited by papers focused on Liver Disease Diagnosis and Treatment (110 papers), Lipid metabolism and disorders (30 papers) and Diet, Metabolism, and Disease (29 papers). Guang Ji collaborates with scholars based in China, United States and Canada. Guang Ji's co-authors include Li Zhang, Tao Wu, Yanqi Dang, Kevin Van der Jeught, Yan Xie, Guowen Li, Wenjun Zhou, Hanchen Xu, Yifei Lü and Hongyi Shen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Guang Ji

273 papers receiving 7.3k citations

Hit Papers

Drug resistance and new therapies in colorectal cancer 2018 2026 2020 2023 2018 2023 2023 100 200 300 400

Peers

Guang Ji
Hor‐Yue Tan Hong Kong
Jiao Guo China
Xin Wang China
Sang Geon Kim South Korea
Jong‐Sup Bae South Korea
Hor‐Yue Tan Hong Kong
Guang Ji
Citations per year, relative to Guang Ji Guang Ji (= 1×) peers Hor‐Yue Tan

Countries citing papers authored by Guang Ji

Since Specialization
Citations

This map shows the geographic impact of Guang Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang Ji more than expected).

Fields of papers citing papers by Guang Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guang Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang Ji. The network helps show where Guang Ji may publish in the future.

Co-authorship network of co-authors of Guang Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Guang Ji. A scholar is included among the top collaborators of Guang Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guang Ji. Guang Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yujing, et al.. (2025). Huang-qin decoction alleviates deoxycholic acid-induced colorectal cancer in mice by regulating gut microbiota. Journal of Ethnopharmacology. 346. 119715–119715. 3 indexed citations
2.
Lu, Lu, et al.. (2024). Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunction. Journal of Pharmaceutical Analysis. 15(5). 101138–101138. 2 indexed citations
4.
Li, Chunlin, Meng Li, Sheng Wei, et al.. (2024). High dietary Fructose Drives Metabolic Dysfunction-Associated Steatotic Liver Disease via Activating ubiquitin-specific peptidase 2/11β-hydroxysteroid dehydrogenase type 1 Pathway in Mice. International Journal of Biological Sciences. 20(9). 3480–3496. 5 indexed citations
5.
Lu, Lu, Mingjie Chen, Guicheng Zhang, et al.. (2024). Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression. Scientific Reports. 14(1). 28519–28519. 1 indexed citations
6.
Gao, Ying, et al.. (2024). Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine. Saudi Pharmaceutical Journal. 32(12). 102213–102213. 1 indexed citations
7.
Yang, Yanling, et al.. (2024). Static magnetic field contributes to osteogenic differentiation of hPDLSCs through the H19/Wnt/β-catenin axis. Gene. 933. 148967–148967. 2 indexed citations
8.
Ji, Lei, Jianying Wang, Lei Zhang, et al.. (2024). Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics. Pharmaceuticals. 17(4). 502–502. 6 indexed citations
9.
Liu, Howe, et al.. (2024). The Landscape of Gut Microbiota and Its Metabolites: A Key to Understanding the Pathophysiology of Pattern in Chinese Medicine. The American Journal of Chinese Medicine. 52(1). 89–122. 1 indexed citations
10.
Zhang, Caiyun, Hongjiao Xiang, Junmin Wang, et al.. (2023). Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology. Journal of Ethnopharmacology. 317. 116676–116676. 3 indexed citations
11.
Zhuang, Xiaoyu, Jiaqi Zhang, Meng Li, et al.. (2023). Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. Frontiers in Endocrinology. 14. 1171397–1171397. 6 indexed citations
12.
Jiang, Yanyu, Xiaogang Zhu, Huan Peng, et al.. (2023). Non‐invasive omics analysis delineates molecular changes in water‐only fasting and its sex‐discriminating features in metabolic syndrome patients. SHILAP Revista de lepidopterología. 4(6). e393–e393. 3 indexed citations
13.
Wang, Junmin, Yifei Lü, Caiyun Zhang, et al.. (2023). Qinggan Huoxue Recipe attenuates Alcoholic Liver Disease by suppressing PI3K/AKT signaling pathway based on network pharmacology. International Journal of Medical Sciences. 20(3). 346–358. 4 indexed citations
14.
Wu, Na, Nan Tang, Jianying Wang, et al.. (2023). DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis. Genes & Diseases. 11(1). 99–102. 2 indexed citations
15.
Liu, Zhidong, et al.. (2022). Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology. SHILAP Revista de lepidopterología. 47 indexed citations
16.
Dai, Liang, Yang Liu, Guang Ji, & Yangxian Xu. (2021). Acupuncture and Derived Therapies for Pain in Palliative Cancer Management: Systematic Review and Meta-Analysis Based on Single-Arm and Controlled Trials. Journal of Palliative Medicine. 24(7). 1078–1099. 7 indexed citations
17.
Zhou, Zhuolong, Kevin Van der Jeught, Yuanzhang Fang, et al.. (2021). An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nature Biomedical Engineering. 5(11). 1320–1335. 78 indexed citations
18.
Liu, Baocheng & Guang Ji. (2017). Sparking Thinking: Studying Modern Precision Medicine Will Accelerate the Progression of Traditional Chinese Medicine Patterns. The Journal of Alternative and Complementary Medicine. 23(7). 502–504. 4 indexed citations
19.
Wang, Miao, et al.. (2013). The Efficacy and Safety of Traditional Chinese Medicine (Jiang Zhi Granule) for Nonalcoholic Fatty Liver: A Multicenter, Randomized, Placebo-Controlled Study. Evidence-based Complementary and Alternative Medicine. 2013. 1–8. 27 indexed citations
20.
Ji, Guang. (2007). Effect of Chinese Medicine Jiangzhi Granula on Hepaticlipid of Nonalcoholic Fatty Liver Disease Rats. Zhonghua zhongyiyao xuekan. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026